Treatment profile
40Hz Gamma Entrainment Therapy
Rewire your brain with precisely tuned sound and light
Availability varies by city. Gabriel checks current qualified providers first, then clearly labels adjacent options that still require service verification.
Duration and price are catalog estimates. Gabriel verifies the current quote, provider credentials, risks, and availability before booking.

A typical visit
Initial assessment of cognitive baseline and neurological history
Duration
30-60 minutes daily, minimum 6-8 week protocol
Listed from
$200
Practitioner access
Verified locally
Category
Biohacking / Longevity
Local access
Find the right local path.
Choose a city or state. Gabriel will carry it into the search, verify the exact offering, and confirm the facts before you book.
About this treatment
What this treatment is designed to do
40Hz Gamma Entrainment Therapy uses precisely calibrated sound and light flickering at 40 cycles per second to entrain your brain's gamma oscillations, the neural frequency associated with peak cognition, memory consolidation, and cellular maintenance. Pioneered by MIT's Li-Huei Tsai at the Picower Institute, this therapy activates your brain's built-in cleanup crew: microglia that clear amyloid plaques, tau tangles, and cellular debris that accumulate with age and disease.
The mechanism is elegant. When neurons fire in synchronized 40Hz patterns, they trigger a cascade of protective responses: microglia shift from inflammatory to phagocytic mode (actively eating debris), astrocytes improve waste clearance via the glymphatic system, oligodendrocytes repair damaged myelin sheaths, and blood vessel function improves throughout the brain. One hour of daily stimulation has been shown to increase amyloid clearance from cerebrospinal fluid by 200% in primate studies.
Phase II clinical trials in Alzheimer's patients demonstrated slowed brain atrophy, preserved white matter integrity, and measurable cognitive improvements. The Cognito Therapeutics GENUS device is now in Phase III nationwide trials. But the implications extend far beyond Alzheimer's: 40Hz stimulation shows promise for Parkinson's, stroke recovery, traumatic brain injury, epilepsy, and general cognitive enhancement. This may be the first truly non-invasive therapy that reverses brain aging at the cellular level.
Visit flow
What happens during the session
Initial assessment of cognitive baseline and neurological history
Fitted with audiovisual stimulation device (headset with LED panels and calibrated speakers)
40Hz flickering light and pulsing sound delivered simultaneously for 30-60 minutes
Sessions feel like sitting in a gently pulsing environment, most find it relaxing
Some experience mild tingling, enhanced mental clarity, or vivid imagery during sessions
Recommended protocol: daily 1-hour sessions for minimum 6-8 weeks
Cognitive and biomarker assessments at regular intervals to track progress
Can be combined with meditation, breathwork, or neurofeedback for enhanced effects
Best for
Why people usually choose this
Anyone concerned about cognitive decline or brain aging
Early-stage Alzheimer's or mild cognitive impairment patients
Those with family history of neurodegenerative disease
Biohackers seeking cognitive enhancement and neuroprotection
Key outcomes
What people hope to improve
Clears amyloid plaques and tau tangles (Alzheimer's hallmarks)
Preserves and repairs white matter/myelin sheaths
Slows brain atrophy and hippocampal volume loss
Improves memory consolidation and cognitive function
Gabriel intelligence
How Gabriel makes this treatment more actionable
Treatment fit
Root-cause context before you book
Gabriel can help decide whether 40hz gamma entrainment therapy fits your symptoms, labs, and recovery goals before you spend money on a session.
Protocol pairing
Connect sessions to a real plan
Gabriel can compare this option with your existing care plan, medications, diagnostics, risks, and follow-up needs before any change is proposed.
Practitioner match
Find the right clinic, not just the nearest one
Gabriel uses available directory signals, location, and modality overlap to surface potential matches, then verifies the facts before booking.
Evidence & safety
What to know before committing
Strong and growing evidence base. MIT research published since 2016 in Nature and other top journals. Phase II human trials showed significant benefits with no adverse effects. Phase III trials ongoing. Safe for daily home use over 2+ years in open-label extension studies. No drug interactions. The GENUS device has FDA breakthrough device designation. This is among the most rigorously studied non-pharmaceutical brain interventions in history.
Related treatments
Similar treatments people compare next
Use these when you want adjacent options in the same category before deciding what to book.
Not sure if this treatment is the right next move?
Tell Gabriel what you are dealing with and what you have already tried. You will get a more useful answer than a generic treatment directory can give.


